Get the Stockscreener App
0.6302
3.32%
0.0157
Icecure Medical Ltd stock is traded at $0.6302, with a volume of 876.00K.
It is up +3.32% in the last 24 hours and up +7.41% over the past month.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
See More
Previous Close:
$0.6145
Open:
$0.65
24h Volume:
876.00K
Relative Volume:
3.07
Market Cap:
$43.61M
Revenue:
$2.98M
Net Income/Loss:
$-15.29M
P/E Ratio:
-2.4685
EPS:
-0.2553
Net Cash Flow:
$-14.25M
1W Performance:
-2.52%
1M Performance:
+7.41%
6M Performance:
-36.06%
1Y Performance:
-51.53%
1-Day Range:
$0.60
$0.651
1-Week Range:
$0.5951
$0.67
52-Week Range:
$0.5401
$1.53
Icecure Medical Ltd Stock (ICCM) Company Profile
Compare ICCM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.6324 | 42.38M | 2.98M | -15.29M | -14.25M | -0.2553 |
|
ABT
Abbott Laboratories
|
110.17 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
343.81 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.94 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.82 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.61 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Icecure Medical Ltd Stock (ICCM) Latest News
IceCure Wins FDA Nod for U.S. Post-Marketing ChoICE Study of ProSense Cryoablation in Low-Risk Breast Cancer - TipRanks
FDA clears IceCure (Nasdaq: ICCM) ProSense post-market ChoICE study in breast cancer - Stock Titan
IceCure Medical (ICCM) Receives FDA Approval for Post-Market Stu - GuruFocus
U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer - PR Newswire
Movement Recap: Is IceCure Medical Ltd showing insider buyingRecession Risk & Fast Exit Strategy with Risk Control - baoquankhu1.vn
IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026 - Finviz
IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026 - Benzinga
IceCure Gains Key ASBrS Backing for ProSense Cryoablation in Low-Risk Breast Cancer - TipRanks
American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer - Sahm
Meme Stocks: Can IceCure Medical Ltd outperform under higher oil pricesTrade Performance Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Bank Watch: Is IceCure Medical Ltd a strong candidate for buy and holdJuly 2025 WrapUp & Smart Swing Trading Techniques - baoquankhu1.vn
Sell Signal: Is IceCure Medical Ltd a stock for growth or value investors2025 Market WrapUp & AI Powered Market Trend Analysis - baoquankhu1.vn
Does IceCure Medical Ltd outperform in volatile markets2025 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn
IceCure Medical Highlights New PLOS One Data Showing ProSense Cryoablation Effective for Breast Fibroadenomas - TipRanks
Independent ProSense study on breast tumors for IceCure (ICCM) - Stock Titan
IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas - PR Newswire
ICCM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
ICCM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ICCM Should I Buy - Intellectia AI
ICCM Completes Key 5-Year Follow-Up in Kidney Cancer Clinical Tr - GuruFocus
IceCure Medical Completes Five-Year Follow Up in ICESECRET Kidney Cancer Cryoablation Study - TipRanks
S P Trends: Is IceCure Medical Ltd subject to activist investor interest2025 Volatility Report & Risk Managed Trade Strategies - baoquankhu1.vn
IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026 - PR Newswire
IceCure Medical Successfully Completes 5-Year Patient Follow Up - GuruFocus
Is IceCure Medical Ltd stock a good dividend stock2025 Technical Overview & Low Risk Profit Maximizing Plans - mfd.ru
IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation - marketscreener.com
Is IceCure Medical Ltd stock overvalued by current metricsWeekly Investment Recap & Technical Pattern Based Buy Signals - mfd.ru
IceCure Medical Ltd. Announces Thomas Hospital of Infirmary Health Installs ProSense®?, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation - marketscreener.com
IceCure Announces Thomas Hospital of Infirmary Health Installs P - GuruFocus
IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense®, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation - PR Newswire
Aug Weekly: Does IceCure Medical Ltd outperform in volatile marketsEarnings Risk Report & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Stock Report: Is IceCure Medical Ltd a strong candidate for buy and hold2025 Retail Activity & Free Community Consensus Stock Picks - baoquankhu1.vn
Is IceCure Medical Ltd subject to activist investor interestWeekly Investment Summary & Stepwise Trade Signal Guides - mfd.ru
Stock Market Recap: How does Universal Corporation compare to its peersInsider Buying & Weekly Momentum Stock Picks - baoquankhu1.vn
What’s the MACD signal for IceCure Medical LtdOptions Play & AI Forecasted Entry/Exit Points - mfd.ru
IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense - Finviz
IceCure Medical Ltd. Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense - marketscreener.com
IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense® - GuruFocus
Why IceCure Medical Ltd stock is popular among millennialsQuarterly Investment Review & Free High Return Stock Watch Alerts - mfd.ru
IceCure CFO Ronen Tsimerman to depart - MSN
How IceCure Medical Ltd stock compares to industry benchmarksDividend Hike & Free Technical Confirmation Trade Alerts - mfd.ru
IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved - Sahm
IceCure Medical CFO to Step Down After Nearly Decade of Service as Succession Search Advances - The Globe and Mail
ICCM: IceCure Medical's CFO Announces Departure - GuruFocus
IceCure Medical (NASDAQ: ICCM) CFO plans departure after 9 years - Stock Titan
Aug Volume: Can IceCure Medical Ltd be recession proofLong Setup & AI Enhanced Trading Signals - baoquankhu1.vn
Is IceCure Medical Ltd stock heavily shortedJuly 2025 Market Mood & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
What is IceCure Medical Ltds 5 year growth outlook2025 Risk Factors & Accurate Technical Buy Alerts - baoquankhu1.vn
Aug Momentum: Will American Resources Corporation benefit from seasonalitySwing Trade & Stock Timing and Entry Methods - baoquankhu1.vn
Quarterly Recap: Is IceCure Medical Ltd stock a good dividend stock2025 Bull vs Bear & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Market Moves: Can IceCure Medical Ltd outperform under higher oil prices2025 Pullback Review & Fast Entry Momentum Alerts - baoquankhu1.vn
Icecure Medical Ltd Stock (ICCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
1.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):